Corvus Pharmaceuticals Inc (CRVS)
Stock-Based Compensation
$8.08M
TTM · Period ending: · USD
CRVS Stock-Based Compensation
Latest reported$8.08Mperiod ending
Latest reported$8.08Mperiod ending
CRVS TTM Stock-Based Comp ($428.00K → $8.08M)
TTM stock-based compensation
High-resolution chart · PNG
CRVS stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,082,000 | |
| 6,729,000 | |
| 5,330,000 | |
| 4,601,000 | |
| 4,053,000 | |
| 3,565,000 | |
| 3,003,000 | |
| 2,730,000 | |
| 2,575,000 | |
| 2,344,000 | |
| 2,147,000 | |
| 2,195,000 | |
| 2,307,000 | |
| 2,445,000 | |
| 2,692,000 | |
| 2,810,000 | |
| 3,248,000 | |
| 3,746,000 | |
| 4,232,000 | |
| 4,730,000 | |
| 4,917,000 | |
| 5,127,000 | |
| 5,747,000 | |
| 6,259,000 | |
| 6,725,000 | |
| 7,240,000 | |
| 7,348,000 | |
| 7,405,000 | |
| 7,450,000 | |
| 7,287,000 | |
| 7,135,000 | |
| 7,069,000 | |
| 6,776,000 | |
| 6,562,000 | |
| 6,229,000 | |
| 5,537,000 | |
| 5,300,000 | |
| 4,855,000 | |
| 3,828,000 | |
| 3,067,000 | |
| 1,925,000 | |
| 867,000 | |
| 428,000 | |
| 142,000 |